Orange Ventures invests in French health-tech startup Biolevate

Orange Ventures invested in French health-tech startup Biolevate in its latest financing round, taking a minority stake. Deal targets life sciences automation, aiming to speed drug development workflows using Biolevate’s agentic AI platform. Orange Business will partner with Biolevate, combining its technology with Enovalife’s clinical research, data, and AI transformation services.